Latest AI and machine learning research in other cancers for healthcare professionals.
BACKGROUND: Aspartame (APM), a widely used sweetener, has been linked to cancers, yet its molecular impact on metabolic dysfunction-associated steatotic liver disease (MASLD) and subsequent hepatocellular carcinoma (HCC) remains undefined. We integrated network toxicology, bulk RNA-seq and docking to map the mechanism. METHODS: APM targets were retrieved from ChEMBL, STITCH and SwissTargetPredicti...
Colorectal cancer (CC) arises from a complex interplay between genetic and epigenetic alterations within the colorectal mucosa, resulting in unchecked cellular proliferation and tumor development. This complexity results in diverse clinical presentations and varying responses to treatment, highlighting the critical need for personalized therapeutic approaches. The epithelial-mesenchymal transition...
BACKGROUND: Non-small cell lung cancer (NSCLC) accounts for approximately 85% of primary pulmonary neoplasms. Complete surgical removal remains the co...
The hallmarks of cancer were introduced by Hanahan and Weinberg as a conceptual organizing framework to distil the complexity of tumours. This concept...
BACKGROUND: Clear cell renal cell carcinoma (ccRCC) is an aggressive tumor with high metastatic potential and therapeutic resistance, yet the role of ...
Glioblastoma (GBM) is one of the most aggressive and lethal primary brain tumors in adults, characterized by dynamic clonal evolution and extensive ge...
Endometrial cancer (EC) is the most common gynaecological malignancy worldwide, yet the prognosis for advanced and recurrent disease remains poor, hig...
BACKGROUND: Palliative care improves the quality of life of people living with life-limiting conditions and their families; however, global access rem...
OBJECTIVES: This study aimed to use machine learning to explore Behçet's syndrome (BS) heterogeneity by integrating immunocyte subpopulations and clin...
Cervical, endometrial, ovarian, vulvar, vaginal, fallopian tube, and gestational trophoblastic neoplasia (GTN) are major gynecologic cancers that sign...
Malignant tumors, including osteosarcoma (OS), are major non-communicable chronic diseases driven by systemic inflammation and oxidative stress. While...
Tumor heterogeneity-encompassing diverse cellular phenotypes, genomic alterations, and micro-environmental contexts-is a principal barrier to effectiv...
RATIONALE AND OBJECTIVE: Anaplastic thyroid carcinoma (ATC) may arise from the progression of differentiated thyroid cancers, but the mechanisms are n...
Breast cancer is a biologically heterogeneous disease in which tumor-intrinsic diversity and the tumor immune microenvironment jointly shape therapeut...
Pancreatic ductal adenocarcinoma (PDAC) is a highly aggressive malignancy with a five-year survival rate below 10%. Regulatory cell death (RCD) plays ...
Neoantigens are critical targets for cancer immunotherapy, yet the relationship between experimentally validated neoantigen burden and antigen process...
Transarterial chemoembolization (TACE) is a cornerstone locoregional therapy for hepatocellular carcinoma (HCC), yet most candidates also have cirrhos...
OBJECTIVES: The need for a cost-effective, rapid, and increasingly accessible alternative to the 21-gene assay prompted this study, which developed a ...
The dynamics of tumor-immune interactions within a complex tumor microenvironment are typically modeled using a system of ordinary differential equati...
BACKGROUND: Gastric cancer (GC) remains a leading cause of cancer-related mortality worldwide, and the prognosis of advanced GC remains poor. Systemat...